Moreover, the enzymes IDO1 and IL4I1 were identified as active players in high-grade serous ovarian cancer, and a correlation between IL4I1 metabolite levels and disease stage was revealed. The gene discussed is IDO1; the disease is ovarian serous adenocarcinoma.